Medicare Data News Today

A new study found female patients (8.15%) had a lower mortality rate when treated by female physicians than male physicians (8.38%).

A new study of over 776,000 patients found that those who were treated by women physicians had lower mortality and readmission rates than those who consulted male physicians.

"Discover the top five large health systems in the U.S. according to a recent report, showcasing their impressive clinical outcomes and operational efficiency."

Objective To determine whether patient-surgeon gender concordance is associated with mortality of patients after surgery in the United States. Design Retrospective observational study. Setting Acute care hospitals in the US. Participants 100% of Medicare fee-for-service beneficiaries aged 65-99 years who had one of 14 major elective or non-elective (emergent or urgent) surgeries in 2016-19. Main outcome measures Mortality after surgery, defined as death within 30 days of the operation. Adjustmen...

Using an innovative method for measuring doctor turnover, Weill Cornell Medicine researchers determined that between 2010 and 2018, the annual rate at which physicians left their practices increased by 43 percent, from 5.3 percent to 7.6 percent a year.

Doctors of osteopathic medicine (DOs) approach treating and preventing illness more holistically, and provide the same quality of care as allopathic doctors (MDs).

New UCLA-led research suggests that patient mortality rates, readmissions, length of stay, and health care spending were virtually identical for elderly hospitalized patients who were treated by physicians with Doctor of Medicine (MD) or Doctor of Osteopathic Medicine (DO) degrees.

/PRNewswire/ -- Denniston Data Inc. (DDI), "The Healthcare Transparency Company," has launched a Texas version of the Official Healthcare Pricing Guide™ (HPG),...

/PRNewswire/ -- Denniston Data Inc. (DDI), "The Healthcare Transparency Company," has launched the Official Healthcare Pricing Guide™ (HPG), U.S. Medical...

Vertical integration may impact some aspects of care for patients with metastatic castration-resistant prostate cancer.